Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice.

Boulday G, Rudini N, Maddaluno L, Blécon A, Arnould M, Gaudric A, Chapon F, Adams RH, Dejana E, Tournier-Lasserve E.

J Exp Med. 2011 Aug 29;208(9):1835-47. doi: 10.1084/jem.20110571. Epub 2011 Aug 22.

2.

Multiple dural lesions mimicking meningiomas in patients with CCM3/PDCD10 mutations.

Labauge P, Fontaine B, Neau JP, Bergametti F, Riant F, Blecon A, Marchelli F, Arnoult M, Lannuzel A, Clanet M, Olschwang S, Denier C, Tournier-Lasserve E.

Neurology. 2009 Jun 9;72(23):2044-6. doi: 10.1212/WNL.0b013e3181a92b13. No abstract available.

PMID:
19506228
3.

Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations.

Boulday G, Blécon A, Petit N, Chareyre F, Garcia LA, Niwa-Kawakita M, Giovannini M, Tournier-Lasserve E.

Dis Model Mech. 2009 Mar-Apr;2(3-4):168-77. doi: 10.1242/dmm.001263. Epub 2009 Feb 2.

4.

Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development.

Petit N, Blécon A, Denier C, Tournier-Lasserve E.

Gene Expr Patterns. 2006 Jun;6(5):495-503. Epub 2006 Feb 7.

PMID:
16455310

Supplemental Content

Loading ...
Support Center